From non-alcoholic fatty liver disease (NAFLD) to steatotic liver disease (SLD): an ongoing journey towards refining the terminology for this prevalent metabolic condition and unmet clinical need
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
From non-alcoholic fatty liver disease (NAFLD) to steatotic liver disease (SLD): an ongoing journey towards refining the terminology for this prevalent metabolic condition and unmet clinical need
Authors
Keywords
-
Journal
METABOLISM-CLINICAL AND EXPERIMENTAL
Volume 147, Issue -, Pages 155664
Publisher
Elsevier BV
Online
2023-07-29
DOI
10.1016/j.metabol.2023.155664
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: a Review of Shared Cardiometabolic Risk Factors
- (2022) Emir Muzurović et al. HYPERTENSION
- Nonalcoholic fatty liver disease and cardiovascular diseases: A Mendelian randomization study
- (2022) Hexiang Peng et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Perivascular Adipose Tissue: Pathophysiological Links With Inflammation, Atherosclerosis, and Thrombosis
- (2021) Niki Katsiki et al. ANGIOLOGY
- Insights into the molecular targets and emerging pharmacotherapeutic interventions for nonalcoholic fatty liver disease
- (2021) Chander K. Negi et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- The role of omics in the pathophysiology, diagnosis and treatment of non-alcoholic fatty liver disease
- (2020) Nikolaos Perakakis et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Making progress in nonalcoholic fatty liver disease (NAFLD) as we are transitioning from the era of NAFLD to dys-metabolism associated fatty liver disease (DAFLD)
- (2020) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Perirenal Adiposity and Other Excessive Intra- and Peri-Organ Fat Depots: What Is the Connection?
- (2019) Niki Katsiki et al. ANGIOLOGY
- Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement
- (2019) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: A proof of concept study
- (2019) Nikolaos Perakakis et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Abnormal Peri-Organ or Intra-Organ Fat Deposition and Vascular Risk
- (2018) Niki Katsiki et al. ANGIOLOGY
- Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome?
- (2018) Niki Katsiki et al. Current Vascular Pharmacology
- Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
- (2018) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started